The project for which Hulsebos received the grant is called DataLibra, which runs from 2024 to 2029. Over those five years, ...

Michael Skinnider and his team have developed DeepMet, a large language model–guided program that can assign a structure to ...

Tabular foundation models are the next major unlock for AI adoption, especially in industries sitting on massive databases of ...

We introduce VeriStruct, a novel framework that extends AI-assisted automated verification from single functions to more complex data structure modules in Verus. VeriStruct employs a planner module to ...

The mainstreaming of AI is turning into a trillion dollar business, yet the two biggest data center real estate firms have ...

The engineers were miserable. And the rest of the business thought they were incompetent.

The U.S. Senate Banking Committee will not have any markup hearings on market structure legislation defining how federal regulators can oversee the industry until next year, punting on a hoped-for ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...